Leqembi® Iqlik™ (lecanemab-irmb) maintenance treatment launched in the U.S.
Go back to Leqembi® Iqlik™ (lecanemab-irmb) maintenance treatment launched in the U.S.| BARNES GROUP, Inc. (NYSE: B) | Delayed: 37.63 +0.44 (1.18%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $37.19 | 52 Week High | $44.27 | |||
| Open | $37.60 | 52 Week Low | $30.07 | |||
| Day High | $37.79 | P/E | 28.73 | |||
| Day Low | $37.04 | EPS | $1.31 | |||
| Volume | 3,359,426 | |||||
| BIOAMBER, Inc. (NASDAQ: BIOA) | Delayed: 15.68 +0.20 (1.29%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.48 | 52 Week High | $8.73 | |||
| Open | $15.70 | 52 Week Low | $2.86 | |||
| Day High | $15.90 | P/E | N/A | |||
| Day Low | $15.52 | EPS | $-3.82 | |||
| Volume | 47,543 | |||||
